Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review

被引:0
作者
Georgia E. Ritchie
Mangalee Fernando
David Goldstein
机构
[1] Prince of Wales Hospital,Department of Medical Oncology and Renal Medicine
[2] University of New South Wales Medical School,Prince of Wales Clinical School
来源
Cancer Chemotherapy and Pharmacology | 2017年 / 79卷
关键词
Gemcitabine; Hemolytic–uremic syndrome; Rituximab; Pancreas adenocarcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 7
页数:6
相关论文
共 89 条
[1]  
Fung MC(1999)A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy Cancer 85 2023-2032
[2]  
Storniolo AM(2007)Gemcitabine-associated thrombotic thrombocytopenic purpura Lancet Oncol 8 634-641
[3]  
Nguyen B(2008)Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer J Clin Gastroenterol 42 551-552
[4]  
Zupancic M(2009)Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution Clin Nephrol 71 130-139
[5]  
Shah PC(2014)Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature Gut Liver 8 109-112
[6]  
Shah-Khan F(2008)Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine Ann Hematol 87 495-496
[7]  
Boeck S(2004)Gemcitabine and hemolytic-uremic syndrome Ann Oncol 15 1575-1576
[8]  
Geiger S(2014)Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series J Chemother 26 169-172
[9]  
Schulz C(2009)Is therapeutic plasma exchanged induced for patients with Gemcitabine-induced Hemolytic Uremic Syndrome? J Clin Apher 24 209-214
[10]  
Glezerman I(2014)Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review J Gastrointest Oncol 5 E30-E33